Diamond Biofund is the first publicly listed evergreen biotech venture capital firm in Taiwan. The founding shareholders include Microbio Group and financial conglomerates - Fubon Financial, Taishin Holdings, and Ruentex Group. With our mission to "Nurture Innovation for Better Quality of Life," Diamond Biofund specializes in biotechnology and medical investments, targeting globally competitive opportunities, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund has invested in more than 20 biotech startups in Taiwan and abroad. In addition to financial investment, Diamond Biofund provides invaluable support to portfolio companies in diverse areas, such as corporate governance, R&D, clinical implementation, business development, and capital market integration, all aimed at driving portfolio growth and delivering investment returns to shareholders.

The TWSE follows national policy while satisfying the needs of domestic and foreign investors, securities issuers and intermediaries, creating the best value for all market participants. The TWSE assists enterprises in listing their securities, raising capital, operational expansion, and spares no effort in augmenting the information transparency of enterprises to assure fair trade in order to protect the rights and privileges of investors. Upholding the spirit of joint collaboration and forward momentum, to serve all participants in the capital market, and aspires to achieve the vision of “creating a viable capital market and bringing about well-being to the people.”

Welcome to the Taipei Exchange (TPEx). We are so very pleased to have you join us today. TPEx has just celebrated its 30th anniversary and advances continued momentum in building a multi-functional and multi-tiered comprehensive exchange. We are at the forefront of balancing government and stakeholders interests to foster sustainable practices. At TPEx, we know the value of diversified financial products and deliver them to enhance financing opportunities as well as having a solid foundation in dual-cored stocks and bonds. In the conceptual and growth stages, all enterprises need support to realize their core value and market potential. It is with this in mind that the TPEx equities market prioritizes supporting micro, small, and medium-sized enterprises (MSMEs). Through our three-tiered structure of the "Mainboard," "Emerging Stock Board (ESB)," " Go Incubation Board (GISA Board)," we have created tailored fundraising and development environments for enterprises at different stages of growth that include investor participation. Our product diversity continues into the bond market where a wide range of products and robust mechanisms always seek to advance green and sustainable bonds to assist private enterprises and government entities in achieving sustainable growth and transformation. In the days to come, I will lead TPEx with an unwavering commitment to innovation and service enhancement. We will harmonize with global trends in sustainable development and pursue the vision of making Taiwan a hub for asset management in Asia.